Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Gets Price Target Bump from Mizuho

Key Points

• Mizuho raised its price target on Senseonics to $20 from $18 and maintained an Outperform rating, implying about 79.7% upside from the prior close.
• SENS shares rose 13.6% to $11.13 on Tuesday. Analyst views remain mixed, with a consensus Hold rating and an average price target of $14.40.
• Third-quarter revenue was $19.56 million, while the company posted a loss of $0.50 per share, slightly missing estimates of a $0.49 loss. Separately, Senseonics raised its 2026 revenue outlook to $68 million–$70 million.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) had its price objective hoisted by analysts at Mizuho from $18.00 to $20.00 in a report released on Tuesday, Benzinga reports. The firm currently has an "outperform" rating on the stock. Mizuho's target price indicates a potential upside of 79.66% from the stock's previous close.

Other research analysts also recently issued research reports about the company. Raymond James Financial upgraded Senseonics Holdings, Inc. Common Stock from an "underperform" rating to a "market perform" rating in a report on Tuesday. Barclays increased their price target on shares of Senseonics Holdings, Inc. Common Stock from $10.00 to $11.00 and gave the company an "equal weight" rating in a research note on Tuesday. HC Wainwright reissued a "buy" rating and set a $14.00 price objective on shares of Senseonics Holdings, Inc. Common Stock in a report on Tuesday. TD Cowen boosted their price objective on shares of Senseonics Holdings, Inc. Common Stock from $15.00 to $17.00 and gave the stock a "buy" rating in a research report on Tuesday. Finally, Stifel Nicolaus restated a "hold" rating and issued a $10.00 target price (up from $9.00) on shares of Senseonics Holdings, Inc. Common Stock in a report on Tuesday. Three equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $14.40.

Senseonics Holdings, Inc. Common Stock Stock Up 13.6%

Shares of SENS stock traded up $1.33 during trading hours on Tuesday, reaching $11.13. 3,253,934 shares of the stock were exchanged, compared to its average volume of 681,334. The business's fifty day moving average is $9.12 and its two-hundred day moving average is $7.26. The firm has a market capitalization of $465.32 million, a P/E ratio of -5.02 and a beta of 1.04. Senseonics Holdings, Inc. Common Stock has a 12-month low of $4.79 and a 12-month high of $13.98. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.74 and a quick ratio of 6.40.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The company reported ($0.50) EPS for the quarter, missing analysts' consensus estimates of ($0.49) by ($0.01). The firm had revenue of $19.56 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. As a group, research analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.31 EPS for the current fiscal year.

Insiders Place Their Bets

In other Senseonics Holdings, Inc. Common Stock news, Director Douglas Roeder purchased 13,953 shares of the firm's stock in a transaction that occurred on Wednesday, August 19th. The stock was purchased at an average price of $8.98 per share, for a total transaction of $125,297.94. Following the purchase, the director directly owned 171,191 shares in the company, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 4.70% of the stock is currently owned by corporate insiders.

Institutional Trading of Senseonics Holdings, Inc. Common Stock

Several institutional investors and hedge funds have recently added to or reduced their stakes in SENS. Integrated Wealth Concepts LLC purchased a new stake in Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at approximately $36,000. Kestra Advisory Services LLC acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the first quarter worth $68,000. The Manufacturers Life Insurance Company purchased a new position in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth about $65,000. State of Wyoming acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth $67,000. Finally, StoneX Group Inc. purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the 3rd quarter valued at $128,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Senseonics Holdings, Inc. Common Stock

Here are the key news stories impacting Senseonics Holdings, Inc. Common Stock this week:

• Positive Sentiment: Q3 revenue reached $19.6 million, up about 140% year over year. Senseonics raised its 2026 revenue outlook to $68 million–$70 million from $62 million–$66 million, above the $64.2 million consensus, and now expects full-year gross margin above 60%. Third-quarter results
• Positive Sentiment: TD Cowen raised its price target to $17 and maintained a Buy rating; HC Wainwright also reaffirmed Buy with a $14 target. TD Cowen recommendations HC Wainwright recommendations
• Neutral Sentiment: Raymond James upgraded SENS from Underperform to Market Perform, a more favorable rating but not a Buy recommendation.
• Negative Sentiment: The company reported a Q3 loss of $0.50 per share, slightly worse than the $0.49 consensus and the $0.43 loss a year earlier. Q3 earnings coverage
• Negative Sentiment: Stifel maintained Hold with a $10 target and Barclays kept Equal Weight with an $11 target—both below the cited share price, tempering the more bullish analyst views. Stifel recommendations Barclays recommendations

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc. is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application. The company's primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.